These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2434320)

  • 1. Sila-substitution--a useful strategy for drug design?
    Tacke R; Zilch H
    Endeavour; 1986; 10(4):191-7. PubMed ID: 2434320
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the medicinal chemistry of silicon: C/Si exchange and beyond.
    Fujii S; Hashimoto Y
    Future Med Chem; 2017 Apr; 9(5):485-505. PubMed ID: 28362125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Odorant design based on the carbon/silicon switch strategy.
    Tacke R; Metz S
    Chem Biodivers; 2008 Jun; 5(6):920-41. PubMed ID: 18618389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry challenges in lead optimization: silicon isosteres in drug discovery.
    Showell GA; Mills JS
    Drug Discov Today; 2003 Jun; 8(12):551-6. PubMed ID: 12821303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can silicon make an excellent drug even better? An in vitro and in vivo head-to-head comparison between loperamide and its silicon analogue sila-loperamide.
    Geyer M; Wellner E; Jurva U; Saloman S; Armstrong D; Tacke R
    ChemMedChem; 2015 May; 10(5):911-24. PubMed ID: 25801200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug stability testing and formulation strategies.
    Wu Z
    Pharm Dev Technol; 2018 Dec; 23(10):941. PubMed ID: 31284808
    [No Abstract]   [Full Text] [Related]  

  • 8. Layer-by-layer self-assembled nanoshells for drug delivery.
    de Villiers MM; Lvov YM
    Adv Drug Deliv Rev; 2011 Aug; 63(9):699-700. PubMed ID: 21718729
    [No Abstract]   [Full Text] [Related]  

  • 9. Clarifications to Pediatric Drug Formulations.
    Walsh K
    Am J Hosp Pharm; 1991 Apr; 48(4):682. PubMed ID: 2042667
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro models for homeopathic high dilutions: the quest for reproducibility.
    Fisher P
    J Altern Complement Med; 2006 May; 12(4):357-8. PubMed ID: 16722784
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous manufacturing and process analytical tools.
    Maniruzzaman M; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):1-2. PubMed ID: 26647292
    [No Abstract]   [Full Text] [Related]  

  • 12. Solubility enhancement and solid-state characterisation.
    Tobyn M
    Pharm Dev Technol; 2018 Sep; 23(7):663. PubMed ID: 30106327
    [No Abstract]   [Full Text] [Related]  

  • 13. [How do you make drugs for children?].
    Pabst JY
    Soins Pediatr Pueric; 2003; (210):24-5. PubMed ID: 12683133
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic Principles of Lyophilization, Part 2.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):20-7. PubMed ID: 27125053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Customizing compounded topical anesthetic preparations.
    Whelan S; Mourad S
    Plast Surg Nurs; 2014; 34(1):25-8. PubMed ID: 24583664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Unexpected instabilities].
    Wolf G
    Hautarzt; 2013 Jun; 64(6):398-9. PubMed ID: 23914372
    [No Abstract]   [Full Text] [Related]  

  • 17. Basics of compounding: Tips and hints: powders, capsules, tablets, suppositories, and sticks, part 1.
    Allen LV
    Int J Pharm Compd; 2014; 18(1):42-5. PubMed ID: 24881340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proporanolol compounding from tablet in infantile hemangiomas.
    Yazici N; Sarialioglu F; Erbay A
    Minerva Pediatr; 2017 Aug; 69(4):369-370. PubMed ID: 28612583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development and testing of new drugs in oncology].
    Bruntsch U
    MMW Munch Med Wochenschr; 1982 Apr; 124(15):356-60. PubMed ID: 6804844
    [No Abstract]   [Full Text] [Related]  

  • 20. [Formation of tablets with the aid of chain extensiometry. II. Methodology of formulation].
    Delacourte-Thibaut A; Devise B; Guyot JC; Traisnel M
    J Pharm Belg; 1974; 29(6):489-522. PubMed ID: 4465436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.